Hung‐Chi Cheng

National Cheng Kung University — Taiwan

Medicine · Health Sciences

9h-index601citations51works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(19), Psoriasis: Treatment and Pathogenesis(14), Peptidase Inhibition and Analysis(10), Cancer Research and Treatments(8), Angiogenesis and VEGF in Cancer(7)

Publications51 total

The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer
Cell Communication and Signaling·2023· 5 citedOpen Access
Supplementary Figure 3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Figure 1 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Data from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
Supplementary movie 1 from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
Supplementary Table 3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Table 2 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Data from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
Supplementary Figure Legends 1-3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Table 3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Table 4 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Table 1 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Data from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary movie 2 from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
Supplementary Figure 1 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Figure 2 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Table 1 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary Figure 2 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
2023Open Access
Supplementary movie 1 from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
Supplementary movie 2 from Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Chung‐Hsi Hsing(17), Yu‐Hsiang Hsu(17), Chien-Hui Chan(17), Ching‐Hua Yeh(17), Chien‐Feng Li(17), Ming‐Shi Chang(17), Yi‐Ching Wang(15), Li‐Wha Wu(10), Wu‐Chou Su(8), Wu‐Wei Lai(8), Hong‐Tai Tzeng(8), Chung-Han Tsai(8), Yu‐Shiuan Wang(8), Yau‐Lin Tseng(7), Yi‐Ting Yen(6), Yi‐Chieh Chen(6), Shih-Wen Pu(6), Yan‐Shen Shan(6), Wen‐Tsan Chang(4), Yen‐An Tang(4)